HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
SGS518
Description
SGS518, a novel antagonist for the 5HT6 subtype of the serotonin receptor, is being developed as a treatment for Cognitive Impairment Associated with Schizophrenia (CIAS).
No brand information found.
